Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Added To Russell 3000 Index

NEW YORK (GenomeWeb News) - Solexa has been added to the Russell 3000 Index, which measures the performance of the 3,000 largest US companies based on total market capitalization, the company said today.
 
Inclusion in the index "should increase Solexa's visibility with institutions that rely on it as part of their investment strategy," said John West, Solexa CEO, in a statement.
 
Solexa's market cap is currently $324 million.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.